71
Participants
Start Date
June 30, 2005
Primary Completion Date
November 30, 2008
Study Completion Date
December 31, 2008
irinotecan
180 mg/m² or 260 mg/m² in 90 minutes every 15 days
5 fluorouracil
400 mg/m² in bolus in day 1 and 2400 mg/m² in 46 hours perfusion
Department of Oncology, CHU, Grenoble
Department of Oncology, IPC, Grenoble
Department of Oncology, ICL, Saint-Priest-en-Jarez
Department of Gastroenterology, CHLS, Pierre-Bénite
Department of Oncology - CHLS, Pierre-Bénite
Institut Claudius Regaud, Toulouse
Collaborators (1)
Pfizer
INDUSTRY
Institut de Recherche Clinique sur les Cancers et le Sang
OTHER